HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: A systematic review and meta-analysis protocol.
<h4>Background</h4>Some mutations in the HIV-1 Gag gene are known to confer resistance to ritonavir-boosted protease inhibitors (PI/r), but their clinical implications remain controversial. This review aims at summarizing current knowledge on HIV-1 Gag gene mutations that are selected un...
Main Authors: | Alex Durand Nka, Georges Teto, Maria Mercedes Santoro, Valantine Ngum Ndze, Désiré Takou, Beatrice Dambaya, Ezechiel Ngoufack Jagni Semengue, Lavinia Fabeni, Carlo-Federico Perno, Vittorio Colizzi, Francesca Ceccherini-Silberstein, Joseph Fokam |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0253587 |
Similar Items
-
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol
by: Ezechiel Ngoufack Jagni Semengue, et al.
Published: (2020-04-01) -
Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
by: Joseph Fokam, et al.
Published: (2020-01-01) -
HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon
by: Desire Takou, et al.
Published: (2019-03-01) -
Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon
by: Joseph Fokam, et al.
Published: (2020-12-01) -
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens
by: Joseph Fokam, et al.
Published: (2020-08-01)